Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3427-3436

  Deckert Schlüter, Martina ^a   Bluethmann, Horst ^b   Rang, Andrea ^a   Hof, Herbert ^c   Schlüter, Dirk ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b F Hoffmann La Roche ^*  (Switzerland)

^c MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL PARASITOSIS; ARTICLE; FEMALE; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII;

ANIMALS; ANTIGENS, CD; BRAIN; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TOXOPLASMOSIS, ANIMAL;

EID: 0032055198     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Luft, B. J., and J. S. Remington. 1988. AIDS commentary: toxoplasmic encephalitis. J. Infect. Dis. 157:1.
2. Schlüter, D., J. Löhler, M. Deckert, H. Hof, and G. Schwendemann. 1991. Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterization of Toxoplasma antigen, infiltrates and major histocompatibility products. J. Neuroimmunol. 31:185.
3. + T cells in mice. J. Immunol. 140:3943.
4. Sher, A., I. Oswald, S. Hieny, and R. T. Gazzinelli. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150:398.
5. Hunter, C. A., S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of γ Interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818.
6. + cells as effectors of IFN-γ dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 178:1465.
7. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516.
8. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286.
9. Schlüter, D., N. Kaefer, O. D. Wiestler, H. Hof, and M. Deckert-Schlüter. 1997. Expression pattern and cellular origin of cytokines in the normal and T. gondii-infected murine brain. Am. J. Pathol. 150:1021.
10. Deckert-Schlüter, M., A. Rang, D. Weiner, S. Huang, O. D. Wiestler, H. Hof, and D. Schlüter. 1996. Interferon-γ receptor deficiency renders mice highly susceptible to toxoplasmosis by a decreased macrophage activation. Lab. Invest. 75:827.
11. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous interferon-gamma mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
12. Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672.
13. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261.
14. Hayashi, S., C. C. Chan, R. T. Gazzinelli, and F. G. Roberge. 1996. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J. Immunol. 156:1476.
15. Chang, H. R., G. E. Grau, and J. C. Pechère. 1990. Role of TNF and IL-1 in infection with Toxoplasma gondii. Immunology 69:33.
16. Pfizenmaier, K., A. Himmler, S. Schütze, P. Scheurich, and M. Krönke. 1992. TNF receptors and TNF signal transduction. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. B. Beutler, ed. Raven Press, New York, p. 439.
17. Neumann, B., A. Luz, K. Pfeffer, and B. Holzmann. 1996. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 184:259.
18. Speiser, D. E., E. Sebzda, T. Ohteki, M. E. Bachmann, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1996. Tumor necrosis factor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3955.
19. Sytwu, H., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
20. L on activated T cells and can be prevented by CD28 costimulation. J. Immunol. 158:598.
21. Lucas, R., P. Juillard., E. Decoster, M. Redar, D. Burger, Y. Donati, C. Giroud, C. Monso-Hinard, T. De Kesel, W. A. Buurman, M. W. Moore, J. Dayer, W. Fiers, H. Bluethmann, and G. E. Grau. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27:1719.
22. Dopp, N. M., A. Mackenzie-Graham, G. C. Otero, and J. E. Merrill. 1997. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75:104.
23. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
24. Pfeffer, K., T. Matsyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes. Cell 73:457.
25. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver Moore, S. Pitts Meek, N. Gillett, K. C. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumor necrosis factor, but normal T-cell development in TNF receptor-2-deficient mice. Int. Immunol. 372:560.
26. Schlüter, D., A. Hein, R. Dörries, and M. Deckert-Schlüter. 1995. Different subsets of T cells in conjunction with NK cells, macrophages, and activated microglia participate in the intracerebral immune response to Toxoplasma gondii in athymic nude and immunocompetent rats. Am. J. Pathol. 146:999.
27. Deckert-Schlüter, M., S. Albrecht, H. Hof, O. D. Wiestler, and D. Schlüter. 1995. Dynamics of the cytokine production in Toxoplasma encephalitis in congenic strains of mice. Immunology 85:408.
28. Stenger, S., H. Thüring, M. Röllinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
29. Green, S. J., J. Aniagolu, and J. J. Raney. 1994. Oxidative metabolism of murine macrophages. In Current Protocols In Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 14.5.1.
30. Bogdan, C., Y. Vodovotz, J. Paik, Q. Xie, and C. Nathan. 1993. Traces of bacterial lipopolysaccharide suppress IFN-γ-induced nitric oxide synthase gene expression in primary mouse macrophages. J. Immunol. 151:301.
31. Deckert-Schlüter, M., D. Schlüter, F. Theisen, O. D. Wiestler, and H. Hof. 1994. Activation of the innate immune system in murine congenital Toxoplasma encephalitis. J. Neuroimmunol. 53:47.
32. Tartaglia, L. A., and D. V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151.
33. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
34. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Intact Peyer's patch organization yet defective formation of B lymphocyte follicles in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci USA 94:6319.
35. Joly, E., Mucke, L., and M. B. A. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283.
36. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147: 3955.
37. + T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J. Immunol. 148:1493.
38. Alexander, J., H. Jebbari, H. Bluethmann, A. Satoskar, and C. W. Roberts. 1996. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr. Top. Microbiol. Immunol. 219:183.
39. Deckert-Schlüter, M., D. Schlüter, H. Hof, O. D. Wiestler, and H. Lassmann. 1994. Differential expression of ICAM-1, VCAM-1, and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J. Neuropathol. Exp. Neurol. 53:457.
40. Peterson, P. K., G. Gekker, S. Hu, and C. C. Chao. 1993. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J. Infect. Dis. 168:1472.
41. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568.
42. Stenger, S., N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1501.
43. Bogdan, C., A. Gessner, W. Solbach, and M. Röllinghoff. 1996. Invasion, control, and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517.
44. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
45. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. W. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.
46. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175.
47. Hunter, C. A., J. S. Abrams, M. H. Beaman, and J. S. Remington. 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect. Immun. 61:4038.
48. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells: a role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 155:4347.